Vita Coco Company, Inc. (COCO) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-13

Key Insights

Jonathan Burth, Chief Operating Officer, executed a significant stock sale of 30,000 shares at $75 per share on 05/12/2026, reducing his beneficial ownership from 87,910 to 57,910 shares, representing a substantial reduction in his equity position.
The sale was conducted pursuant to a Rule 10b5-1 trading plan, indicating a pre-planned transaction rather than opportunistic selling, which reduces concerns about negative sentiment but still signals reduced conviction in near-term performance.
Burth simultaneously exercised 30,000 stock options at $10.178 and immediately sold them at $75, capturing a significant profit of approximately $2.1 million, suggesting he exercised vested options specifically to fund the planned sale.
The executive maintains a substantial portfolio of unvested and vested options across multiple grant dates (238,267 total option shares), indicating significant ongoing equity incentives and long-term compensation alignment with the company.

Want the newest filings?

This analysis covers the filing from 2026-05-13. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-05-11

COO Jonathan Burth executed a significant net sale of 20,000 shares at $70/share (generating ~$1.4M) while simultaneously acquiring 20,000 shares at $10.178 through what appears to be a compensation grant, suggesting a rebalancing of equity compensation rather than pure conviction buying.
The sale was conducted pursuant to a Rule 10b5-1 trading plan established in advance, indicating this was a pre-planned transaction not reflective of current market sentiment and likely part of a structured diversification strategy.
Burth maintains substantial optionality with 280,912 unexercised stock options at various strike prices ($10.18-$33.36), representing significant future equity upside if performance and vesting conditions are met, with multiple tranches still vesting through 2035.
The large spread between the acquisition price ($10.178) and sale price ($70) on the same transaction date indicates substantial stock appreciation, though the 10b5-1 plan mechanics suggest the sale timing may have been predetermined rather than opportunistic.

Filed: 2026-05-11

Chief Commercial Officer Charles van Es sold 8,561 shares at $70 per share on 05/08/2026 through a Rule 10b5-1 trading plan, generating approximately $599,270 in proceeds while retaining 67,130 shares of direct beneficial ownership.
Van Es maintains substantial equity exposure through approximately 232,513 unexercised stock options across 8 tranches with exercise prices ranging from $10.18 to $33.36, indicating long-term alignment with company performance.
The insider sale was executed via a pre-arranged Rule 10b5-1 plan, suggesting a systematic and legally compliant divestment strategy rather than a signal of negative sentiment about the company's prospects.
Van Es retains significant option holdings vesting through 2035, with performance-based options already vested as of February 2026, demonstrating the company's use of equity incentives tied to achievement metrics.

Filed: 2026-05-04

Chief Commercial Officer Charles van Es sold 2,000 shares at $66.87 on May 1, 2026, pursuant to a Rule 10b5-1 trading plan, reducing his direct holdings to 75,691 shares. This represents a pre-planned, systematic sale rather than opportunistic selling, suggesting confidence in the company's trajectory.
Van Es maintains substantial equity compensation with 232,507 stock options across multiple vesting schedules, with exercise prices ranging from $10.18 to $33.36, indicating significant accumulated compensation tied to company performance over several years.
The sale volume is relatively modest (2,000 shares) compared to his total beneficial ownership position, suggesting the executive is maintaining meaningful exposure to Vita Coco rather than divesting significantly.
Several options have fully vested or are currently exercisable, particularly the options at $10.178 strike price (81,050 shares combined), providing the executive with substantial optionality to increase equity ownership if desired.

Filed: 2026-05-01

Executive Chairman Michael Kirban sold 50,000 shares at $68 per share on 04/30/2026 under a Rule 10b5-1 trading plan, generating approximately $3.4 million in proceeds, indicating pre-planned portfolio rebalancing rather than distress selling.
Kirban maintains substantial beneficial ownership of 2,138,529 common shares directly and indirectly through trusts, demonstrating significant continued alignment with shareholder interests despite the stock sale.
Kirban holds substantial unexercised stock option positions totaling 1,251,923 shares with exercise prices ranging from $10.18 to $32.78, with vesting schedules extending through March 2026, representing meaningful upside leverage to future stock appreciation.

Filed: 2026-05-01

Chief Operating Officer Jonathan Burth executed a Rule 10b5-1 trading plan involving systematic sales of 80,000 common shares across April 29-30, 2026 at prices ranging from $62.50 to $67.50, suggesting planned diversification rather than emergency liquidity needs.
Burth acquired 80,000 shares through non-qualified stock options exercised at $10.178 per share while simultaneously selling shares at significantly higher prices ($62.50-$67.50), indicating substantial unrealized gains and confidence in option grants.
The officer maintains a substantial option portfolio with 359,912 options outstanding across multiple vesting schedules and strike prices, with recent vesting events in February 2026 demonstrating active performance-based compensation realization.
The use of Rule 10b5-1 plan for sales indicates pre-planned trading activity that complies with insider trading restrictions, reducing the likelihood of negative undisclosed information driving the transactions.

Filed: 2026-04-30

CEO Martin Roper executed significant stock sales totaling 45,544 shares on April 28-29, 2026, at prices ranging from $51.13 to $59.348, generating approximately $2.4 million in proceeds through a Rule 10b5-1 trading plan.
Roper simultaneously acquired 45,544 non-qualified stock options at the $10.178 exercise price, suggesting a strategic compensation structure that may indicate confidence in future stock appreciation despite near-term sales.
The insider's total direct beneficial ownership decreased from 323,484 to 298,484 common shares after transactions, while maintaining substantial indirect holdings through family trusts (totaling approximately 648,893 shares) and significant unexercised option positions (1.04 million shares).
The use of a Rule 10b5-1 pre-planned trading arrangement indicates these sales were likely scheduled in advance rather than reactive to negative developments, reducing concerns about imminent adverse news.

Filed: 2026-04-28

CEO Martin Roper executed a Rule 10b5-1 trading plan with symmetric transactions: purchasing 50,000 shares at $10.178 and selling 50,000 shares at $50 across two dates (04/24 and 04/27), suggesting pre-arranged systematic trading rather than directional conviction.
Roper significantly increased his stock option holdings with new grants totaling 40,950 shares at $10.178 exercisable until 01/11/2031, indicating recent equity compensation alignment with the company's strategic direction.
Total beneficial ownership includes substantial indirect holdings through family trusts (Chris Roper: 215,631 shares, Peter Roper: 216,131 shares, Thomas Roper: 216,131 shares) plus spouse holdings of 41,200 shares, reflecting concentrated family control of approximately 689,000 shares indirectly.
The trading plan execution at a significant spread ($50 sale price vs. $10.178 purchase/grant price) suggests confidence in stock valuation, though the mechanical nature of Rule 10b5-1 compliance limits interpretation of insider sentiment.

Filed: 2026-04-17

Insider Martin Roper, the Chief Executive Officer, exercised 25,000 stock options and immediately sold the shares, indicating he may be cashing out a portion of his equity stake in the company.
Roper also holds significant indirect beneficial ownership in the company through family trusts, suggesting he and his family have a substantial economic interest in Vita Coco.
The company has granted Roper a series of non-qualified stock options with varying exercise prices and vesting schedules, providing him with long-term incentives to drive the company's performance.

Filed: 2026-04-16

Insider Martin Roper has exercised and sold a significant number of non-qualified stock options, indicating potential insider selling activity.
Roper holds a large number of stock options, which could suggest he is taking advantage of the current stock price to diversify his holdings.
The transaction details indicate Roper is selling shares pursuant to a Rule 10b5-1 trading plan, which may provide some reassurance about the planned nature of the transactions.

Filed: 2026-04-16

Kenneth Sadowsky, a director of Vita Coco Company, Inc., sold 3,900 shares of the company's common stock on April 15, 2026 at a weighted average price of $48.93 per share.
The sale was made pursuant to a Rule 10b5-1 trading plan, indicating the transaction was pre-planned and not based on material non-public information.
Sadowsky still owns 586,566 shares of Vita Coco directly, as well as 27,300 non-qualified stock options that are fully vested and exercisable.

Filed: 2026-04-14

Martin Roper, the CEO of Vita Coco Company, Inc., has exercised 29,456 stock options and sold 29,456 shares of the company's common stock.
The sales of shares were made pursuant to a Rule 10b5-1 trading plan, indicating pre-planned transactions rather than opportunistic selling.
Roper still maintains a significant ownership stake in the company, with 298,484 shares held directly and an additional 688,093 shares held indirectly through family trusts.

Filed: 2026-03-23

Corey Baker, the Chief Financial Officer of Vita Coco Company, Inc., sold 2,000 shares of common stock at $55.45 per share on March 19, 2026.
Baker continues to hold a significant number of stock options, including 9,205 options with a $16.91 exercise price, 13,481 options with a $24.35 exercise price, and others with higher exercise prices.
The sale of shares was made pursuant to a Rule 10b5-1 trading plan, indicating a pre-planned transaction rather than a discretionary sale.

Filed: 2026-03-18

The reporting person, Jonathan Burth, who is the Chief Operating Officer of Vita Coco Company, Inc., has engaged in a series of transactions involving the company's common stock and stock options.
Burth has exercised multiple batches of non-qualified stock options to acquire a total of 40,000 shares of Vita Coco's common stock, and has subsequently sold 40,000 shares on the open market.
The transactions appear to be part of a 10b5-1 trading plan, which suggests the insider trading was pre-planned and not based on any material non-public information.

Filed: 2026-03-18

The reporting person, Charles van Es, who is the Chief Commercial Officer of Vita Coco Company, Inc. (COCO), has sold 2,000 shares of common stock at an average price of $57.98 per share.
Van Es holds a significant number of non-qualified stock options, which vest over several years, suggesting he has a long-term commitment to the company.
The stock options have various exercise prices, ranging from $10.178 to $33.36, indicating the company has granted options to van Es at different times and under different vesting schedules.

Filed: 2026-03-12

Jonathan Burth, the Chief Operating Officer of Vita Coco Company, Inc., disposed of 818 shares of common stock through a stock withholding transaction to cover tax obligations, reducing his direct ownership to 77,910 shares.
Burth holds a significant number of non-qualified stock options, totaling over 400,000 shares, with various vesting schedules and performance conditions, indicating a long-term commitment to the company.
The stock option grants with performance conditions have seen some vesting based on meeting the set targets, suggesting the company is achieving its operational goals.

Filed: 2026-03-12

Corey Baker, the Chief Financial Officer, has disposed of a significant number of shares in the company, potentially indicating a change in his outlook or the need to liquidate some holdings.
The majority of Baker's stock options are vested or will vest in the near future, suggesting he has significant equity incentives tied to the company's performance.
The timing and amount of Baker's share dispositions may be worth monitoring to gauge any potential shifts in management's confidence or the company's financial health.

Filed: 2026-03-12

Jane Prior, the Chief Marketing Officer of Vita Coco Company, Inc. (COCO), has disposed of 818 shares of common stock to cover tax withholding obligations, indicating routine insider selling activity.
Prior holds a significant number of non-qualified stock options, with the most recent grant in March 2035, suggesting continued management commitment to the company.
The vesting schedules of Prior's stock options indicate a mix of time-based and performance-based vesting, providing incentives for both short-term and long-term value creation.

Other reports for Vita Coco Company, Inc.

Quarterly Report Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.